Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study

Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study

<i>Background</i>: Checkpoint inhibitors are a standard of care in the treatment of advanced renal cell carcinoma (RCC) and urothelial carcinoma (UC). Patients with these tumors often suffer from concomitant chronic kidney disease (CKD). Limited data are available on the efficacy and tox...

Full description

Bibliographic Details
Main Authors: Florian Seydel, Susanne Delecluse, Martin Zeier, Tim Holland-Letz, Georg Martin Haag, Anne Katrin Berger, Barbara Christine Grün, Nina Bougatf, Markus Hohenfellner, Stefan Duensing, Dirk Jäger, Stefanie Zschäbitz
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
checkpoint inhibitor
chronic kidney disease
renal cell carcinoma
urothelial carcinoma
Online Access:https://www.mdpi.com/2072-6694/13/7/1623

Internet

https://www.mdpi.com/2072-6694/13/7/1623

Similar Items